Kanada - engleski - Health Canada

westcan pharmaceuticals ltd. - acetylsalicylic acid - tablet - 325mg - acetylsalicylic acid 325mg - salicylates

Kanada - engleski - Health Canada

wes pak products ltd. - acetylsalicylic acid - tablet - 325mg - acetylsalicylic acid 325mg - salicylates

Kanada - engleski - Health Canada

prodemdis enr. - acetylsalicylic acid - tablet - 325mg - acetylsalicylic acid 325mg - salicylates

Kanada - engleski - Health Canada

cellchem pharmaceuticals inc. - acetylsalicylic acid - tablet - 325mg - acetylsalicylic acid 325mg - salicylates

Kanada - engleski - Health Canada

cellchem pharmaceuticals inc. - acetylsalicylic acid - tablet - 500mg - acetylsalicylic acid 500mg - salicylates

Kanada - engleski - Health Canada

cellchem pharmaceuticals inc. - acetylsalicylic acid - tablet - 325mg - acetylsalicylic acid 325mg - salicylates

Kanada - engleski - Health Canada

cellchem pharmaceuticals inc. - acetylsalicylic acid - tablet - 500mg - acetylsalicylic acid 500mg - salicylates

Australija - engleski - Department of Health (Therapeutic Goods Administration)

bausch & lomb australia pty ltd - acetylcholine chloride, quantity: 10 mg/ml - diluent, not applicable - excipient ingredients: sodium acetate; magnesium chloride hexahydrate; potassium chloride; calcium chloride dihydrate; water for injections - miochol-e is used to obtain complete miosis of the iris in seconds after placement of the intraocular lens (iol) in cataract surgery; and in penetrating keratoplasty, iridectomy and other anterior segment surgery where rapid miosis may be required.

Malta - engleski - Medicines Authority

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - acetylcysteine - concentrate for solution for infusion - acetylcysteine 200 mg/ml - all other therapeutic products

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

exela pharma sciences, llc - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine solution, usp is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions in such conditions as: acetylcysteine is contraindicated in those patients who are sensitive to it. acetylcysteine solution, usp administered orally, is indicated as an antidote to prevent or lessen hepatic injury which may occur following the ingestion of a potentially hepatotoxic quantity of acetaminophen. it is essential to initiate treatment as soon as possible after the overdose and, in any case, within 24 hours of ingestion. there are no contraindications to oral administration of acetylcysteine in the treatment of acetaminophen overdose.